Description

POLMOST plus Tablets
Composition:- Polmacoxib 2 mg+ Paracetamol 325 mg

POLMOST plus Tablets – Polmacoxib & Paracetamol Tablets combine Polmacoxib, a novel first-in-class orally active NSAID that acts as a dual inhibitor of COX-2 and CA enzyme. Being a selective inhibitor of COX-2, it helps to reduce gastrointestinal side effects and has a higher affinity towards CA reducing cardiovascular side effects unlike Celecoxib.
Paracetamol- An antipyretic drug synergistically improves and alleviates symptoms of Osteoarthritis and Knee Arthritis.

Key Points of Polmacoxib & Paracetamol Tablets – POLMOST Plus Tablets
• First-in-Class NSAID: Polmacoxib is the world’s first-in-class NSAID offering selective COX-2 inhibition, ensuring targeted anti-inflammatory action.
• Dual Mechanism of Action: The combination of Polmacoxib and Paracetamol provides synergistic pain relief by blocking pain pathways through two complementary mechanisms.
• Superior Gastrointestinal Safety: Unlike conventional NSAIDs such as Celecoxib or Etoricoxib, Polmacoxib is associated with minimal or no gastrointestinal side effects, making it safer for long-term use.
• Better Cardiovascular Profile: Polmacoxib demonstrates improved cardiac safety compared to other COX-2 inhibitors, reducing risks linked with prolonged therapy.

Can be Prescribed by:
• Cardiologists 
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.